These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

170 related items for PubMed ID: 19996484

  • 1. Is melatonin involved in the irritable bowel syndrome?
    Radwan P, Skrzydlo-Radomanska B, Radwan-Kwiatek K, Burak-Czapiuk B, Strzemecka J.
    J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():67-70. PubMed ID: 19996484
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of urinary 6-hydroxymelatonin sulphate excretion in women at different age with irritable bowel syndrome.
    Wisniewska-Jarosinska M, Chojnacki J, Konturek S, Brzozowski T, Smigielski J, Chojnacki C.
    J Physiol Pharmacol; 2010 Jun; 61(3):295-300. PubMed ID: 20610859
    [Abstract] [Full Text] [Related]

  • 3. [Serum serotonin concentration and urine 5-hydroxyindole acetic acid excretion in patients with irritable bowel syndrome].
    Moskwa A, Chojnacki J, Wiśiewska-Jarosińska M, Stec-Michalska K, Szadkowski K, Smigielski J, Chojnacki C.
    Pol Merkur Lekarski; 2007 May; 22(131):366-8. PubMed ID: 17679369
    [Abstract] [Full Text] [Related]

  • 4. 5-hydroxytryptamine signalling in irritable bowel syndrome with diarrhoea: effects of gender and menstrual status.
    Houghton LA, Brown H, Atkinson W, Morris J, Fell C, Whorwell PJ, Lockhart S, Keevil B.
    Aliment Pharmacol Ther; 2009 Nov 01; 30(9):919-29. PubMed ID: 19691669
    [Abstract] [Full Text] [Related]

  • 5. Different segmental transit times in patients with irritable bowel syndrome and "normal" colonic transit time: is there a correlation with symptoms?
    Bouchoucha M, Devroede G, Dorval E, Faye A, Arhan P, Arsac M.
    Tech Coloproctol; 2006 Dec 01; 10(4):287-96. PubMed ID: 17115321
    [Abstract] [Full Text] [Related]

  • 6. 5-HTTLPR and STin2 polymorphisms in the serotonin transporter gene and irritable bowel syndrome: effect of bowel habit and sex.
    Niesler B, Kapeller J, Fell C, Atkinson W, Möller D, Fischer C, Whorwell P, Houghton LA.
    Eur J Gastroenterol Hepatol; 2010 Jul 01; 22(7):856-61. PubMed ID: 19561511
    [Abstract] [Full Text] [Related]

  • 7. Abnormal intestinal permeability in subgroups of diarrhea-predominant irritable bowel syndromes.
    Dunlop SP, Hebden J, Campbell E, Naesdal J, Olbe L, Perkins AC, Spiller RC.
    Am J Gastroenterol; 2006 Jun 01; 101(6):1288-94. PubMed ID: 16771951
    [Abstract] [Full Text] [Related]

  • 8. Influence of melatonin on symptoms of irritable bowel syndrome in postmenopausal women.
    Chojnacki C, Walecka-Kapica E, Lokieć K, Pawłowicz M, Winczyk K, Chojnacki J, Klupińska G.
    Endokrynol Pol; 2013 Jun 01; 64(2):114-20. PubMed ID: 23653274
    [Abstract] [Full Text] [Related]

  • 9. Symptomatic efficacy of beidellitic montmorillonite in irritable bowel syndrome: a randomized, controlled trial.
    Ducrotte P, Dapoigny M, Bonaz B, Siproudhis L.
    Aliment Pharmacol Ther; 2005 Feb 15; 21(4):435-44. PubMed ID: 15709995
    [Abstract] [Full Text] [Related]

  • 10. [Melatonin secretion and metabolism in patients with irritable bowel syndrome].
    Stepień A, Moskwa-Fortuna A, Wisniewska-Jarosińska M, Harasiuk A, Chojnacki J.
    Pol Merkur Lekarski; 2009 May 15; 26(155):440-3. PubMed ID: 19606692
    [Abstract] [Full Text] [Related]

  • 11. Impaired intestinal barrier integrity in the colon of patients with irritable bowel syndrome: involvement of soluble mediators.
    Piche T, Barbara G, Aubert P, Bruley des Varannes S, Dainese R, Nano JL, Cremon C, Stanghellini V, De Giorgio R, Galmiche JP, Neunlist M.
    Gut; 2009 Feb 15; 58(2):196-201. PubMed ID: 18824556
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and tolerability of alosetron for the treatment of irritable bowel syndrome in women and men: a meta-analysis of eight randomized, placebo-controlled, 12-week trials.
    Rahimi R, Nikfar S, Abdollahi M.
    Clin Ther; 2008 May 15; 30(5):884-901. PubMed ID: 18555935
    [Abstract] [Full Text] [Related]

  • 13. [Small intestine motility and gastrointestinal hormone levels in irritable bowel syndrome].
    Zhao JH, Dong L, Hao XQ.
    Nan Fang Yi Ke Da Xue Xue Bao; 2007 Oct 15; 27(10):1492-5. PubMed ID: 17959521
    [Abstract] [Full Text] [Related]

  • 14. Altered 5-hydroxytryptamine signaling in patients with constipation- and diarrhea-predominant irritable bowel syndrome.
    Atkinson W, Lockhart S, Whorwell PJ, Keevil B, Houghton LA.
    Gastroenterology; 2006 Jan 15; 130(1):34-43. PubMed ID: 16401466
    [Abstract] [Full Text] [Related]

  • 15. Expression and role of 5-HT7 receptor in brain and intestine in rats with irritable bowel syndrome.
    Zou BC, Dong L, Wang Y, Wang SH, Cao MB.
    Chin Med J (Engl); 2007 Dec 05; 120(23):2069-74. PubMed ID: 18167178
    [Abstract] [Full Text] [Related]

  • 16. A preliminary study of melatonin in irritable bowel syndrome.
    Saha L, Malhotra S, Rana S, Bhasin D, Pandhi P.
    J Clin Gastroenterol; 2007 Jan 05; 41(1):29-32. PubMed ID: 17198061
    [Abstract] [Full Text] [Related]

  • 17. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.
    Coëffier M, Gloro R, Boukhettala N, Aziz M, Lecleire S, Vandaele N, Antonietti M, Savoye G, Bôle-Feysot C, Déchelotte P, Reimund JM, Ducrotté P.
    Am J Gastroenterol; 2010 May 05; 105(5):1181-8. PubMed ID: 19997094
    [Abstract] [Full Text] [Related]

  • 18. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea.
    Talley NJ, Dennis EH, Schettler-Duncan VA, Lacy BE, Olden KW, Crowell MD.
    Am J Gastroenterol; 2003 Nov 05; 98(11):2454-9. PubMed ID: 14638348
    [Abstract] [Full Text] [Related]

  • 19. Risk factors for irritable bowel syndrome in Turkish population: role of food allergy.
    Uz E, Türkay C, Aytac S, Bavbek N.
    J Clin Gastroenterol; 2007 Apr 05; 41(4):380-3. PubMed ID: 17413606
    [Abstract] [Full Text] [Related]

  • 20. The epidemiological aspects of irritable bowel syndrome in Southeastern Anatolia: a stratified randomised community-based study.
    Yilmaz S, Dursun M, Ertem M, Canoruc F, Turhanoğlu A.
    Int J Clin Pract; 2005 Mar 05; 59(3):361-9. PubMed ID: 15857337
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.